Archive: 2026/02
Immunosuppressants and Cancer History: What You Need to Know About Recurrence Risk
New research shows immunosuppressants like anti-TNF drugs and methotrexate do not increase cancer recurrence risk, even when started soon after cancer treatment. Learn what the data really says and how treatment guidelines have changed.
Bioequivalence Studies: What the FDA Requires Generic Drug Manufacturers to Prove
Bioequivalence studies prove generic drugs work the same as brand-name versions. The FDA requires strict testing to ensure identical absorption and effectiveness, using the 80-125% rule for most drugs. This process keeps generics safe, affordable, and reliable.